Financial giants have made a conspicuous bullish move on Eli Lilly. Our analysis of options history for Eli Lilly LLY revealed 156 unusual trades.
Delving into the details, we found 55% of traders were bullish, while 25% showed bearish tendencies. Out of all the trades we spotted, 108 were puts, with a value of $6,109,986, and 48 were calls, valued at $4,158,923.
Expected Price Movements
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $390.0 to $1180.0 for Eli Lilly during the past quarter.
Volume & Open Interest Development
In terms of liquidity and interest, the mean open interest for Eli Lilly options trades today is 212.74 with a total volume of 6,503.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Eli Lilly's big money trades within a strike price range of $390.0 to $1180.0 over the last 30 days.
Eli Lilly Option Activity Analysis: Last 30 Days
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | CALL | SWEEP | BEARISH | 04/11/25 | $22.45 | $22.4 | $22.4 | $815.00 | $223.7K | 54 | 316 |
| LLY | PUT | SWEEP | BULLISH | 06/18/26 | $87.3 | $84.7 | $85.94 | $770.00 | $222.7K | 10 | 67 |
| LLY | CALL | SWEEP | BULLISH | 04/11/25 | $22.55 | $22.35 | $22.55 | $815.00 | $169.5K | 54 | 115 |
| LLY | PUT | SWEEP | NEUTRAL | 06/18/26 | $88.65 | $82.95 | $85.95 | $770.00 | $163.3K | 10 | 34 |
| LLY | PUT | SWEEP | BULLISH | 06/18/26 | $86.95 | $84.85 | $85.39 | $770.00 | $102.4K | 10 | 133 |
About Eli Lilly
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Having examined the options trading patterns of Eli Lilly, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
Where Is Eli Lilly Standing Right Now?
- With a volume of 959,932, the price of LLY is down -1.09% at $816.88.
- RSI indicators hint that the underlying stock may be approaching oversold.
- Next earnings are expected to be released in 30 days.
Professional Analyst Ratings for Eli Lilly
In the last month, 1 experts released ratings on this stock with an average target price of $1100.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access. * Maintaining their stance, an analyst from Wells Fargo continues to hold a Overweight rating for Eli Lilly, targeting a price of $1100.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Eli Lilly, Benzinga Pro gives you real-time options trades alerts.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
